ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...

IGIB and the Serum Institute of India aims to make sickle cell treatment accessible to India's tribal communities, where the ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...

In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the ...

CRISPR has turned a simple fungus into a fast-growing, meat-like protein source with impressively low environmental impact.

Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...

India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...

Study shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types.

For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...

The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of global companies.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...